New Assay Could Revolutionize Acute Myeloid Leukemia Detection
A novel assay that identifies a unique molecular marker in acute myeloid leukemia patients may revolutionize how the disease is detected.
Read MorePosted by Andy Lundin | Nov 13, 2023 | Leukemia |
A novel assay that identifies a unique molecular marker in acute myeloid leukemia patients may revolutionize how the disease is detected.
Read MorePosted by Andy Lundin | Nov 8, 2023 | Leukemia, Sequencing Systems |
Sequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read MorePosted by Andy Lundin | Oct 25, 2023 | Leukemia |
Alercell’s leukemia test will use terminal erythroid differentiation for prognostic classification in patients with myeloid malignancies.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Cancer |
Researchers detected cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a high risk of developing cancer.
Read MorePosted by Andy Lundin | Oct 23, 2023 | Cancer, Molecular Diagnostics |
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read More